Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians

Background Risk factors for B-cell non-Hodgkin lymphoma (B-NHL) have not been assessed among Palestinian Arabs (PA) and Israeli Jews (IJ). Methods In a case-control study we investigated self-reported medical and lifestyle exposures, reporting odds ratios (ORs) and 95% confidence intervals [CIs], by ethnicity, for overall B-NHL and subtypes. Results We recruited 823 cases and 808 healthy controls. Among 307 PA/516 IJ B-NHL cases (mean age at diagnosis = 51 [±17] versus 60 [±15] years, respectively) subtype distributions differed, with diffuse large B-cell lymphoma (DLBCL) being prominent among PA (71%) compared to IJ (41%); follicular lymphoma (FL), was observed in 14% versus 28%, and marginal zone lymphoma, in 2% versus 14%, respectively. Overall B-NHL in both populations was associated with recreational sun exposure OR = 1.43 [CI:1.07–1.91], black hair-dye use OR = 1.70 [CI:1.00–2.87], hospitalization for infection OR = 1.68 [CI:1.34–2.11], and first-degree relative with hematopoietic cancer, OR = 1.69 [CI:1.16–2.48]. An inverse association was noted with alcohol use, OR = 0.46 [CI:0.34–0.62]. Subtype-specific exposures included smoking (FL, OR = 1.46 [CI:1.01–2.11]) and >monthly indoor pesticide use (DLBCL, OR = 2.01 [CI:1.35–3.00]). Associations observed for overall B-NHL in PA only included: gardening OR = 1.93 [CI:1.39–2.70]; history of herpes, mononucleosis, rubella, blood transfusion (OR>2.5, P<0.01 for all); while for IJ risk factors included growing fruits and vegetables, OR = 1.87 [CI:1.11–3.15]; and self-reported autoimmune diseases, OR = 1.99 [CI:1.34–2.95]. Conclusions In these geographically proximate populations we found some unique risk factors for B-NHL. Heterogeneity in the observed associations by ethnicity could reflect differences in lifestyle, medical systems, and reporting patterns, while variations by histology infer specific etiologic factors for lymphoma subtypes.

[1]  A. Nagler,et al.  Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B , 2016, Haematologica.

[2]  J. Cerhan,et al.  Familial predisposition and genetic risk factors for lymphoma. , 2015, Blood.

[3]  Angela Brooks-Wilson,et al.  Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. , 2015, American journal of epidemiology.

[4]  B. Alexander,et al.  Relationship between ambient ultraviolet radiation and non‐Hodgkin lymphoma subtypes: A U.S. population‐based study of racial and ethnic groups , 2015, International journal of cancer.

[5]  K. Hemminki,et al.  Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  D. Weisenburger,et al.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.

[7]  I. Burney,et al.  Dietary and lifestyle factors and risk of non-hodgkin's lymphoma in Oman. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[8]  C. la Vecchia,et al.  Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  M. Thun,et al.  The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study , 2012, Cancer Causes & Control.

[10]  Alexandra G. Smith,et al.  Epidemiology of lymphomas , 2011, Histopathology.

[11]  D. Locker,et al.  Long-term Dental Visiting Patterns and Adult Oral Health , 2010, Journal of dental research.

[12]  K. Mazan-Mamczarz,et al.  Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction. , 2009, Blood.

[13]  S. Akhtar,et al.  Malignant lymphoma in Al-Qassim, Saudi Arabia, reclassified according to the WHO classification. , 2009, Saudi medical journal.

[14]  C. Loffredo,et al.  Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes , 2009, Cancer Causes & Control.

[15]  J. Pliskin,et al.  Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  David C Christiani,et al.  Second hand smoke, age of exposure and lung cancer risk. , 2007, Lung cancer.

[17]  E. Engels Infectious Agents as Causes of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[18]  A. Bordoni,et al.  Epidemiology of hematological malignancies. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  D. Weisenburger,et al.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). , 2006, Blood.

[20]  David Laniado,et al.  The Risk of Cancer following Hospitalization for Infection in Infancy: A Population-Based Cohort Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[21]  P. Brennan,et al.  Tobacco smoking, alcohol drinking and non‐Hodgkin's lymphoma: A European multicenter case‐control study (Epilymph) , 2006, International journal of cancer.

[22]  Fred R. Dee,et al.  Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. , 2005, The Lancet. Oncology.

[23]  N. Almasri,et al.  Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies. , 2004, Saudi medical journal.

[24]  U. Laaser,et al.  Prevalence and risk factors of HBsAg in Gaza: implications for prevention and control. , 2002, The Journal of infection.

[25]  O. Paltiel,et al.  The incidence of lymphoma in first‐degree relatives of patients with Hodgkin disease and non‐Hodgkin lymphoma , 2000, Cancer.

[26]  N. Hou,et al.  Epidemiology and etiology of non-hodgkin lymphoma. , 2015, Cancer treatment and research.

[27]  J. Kattan,et al.  Type distribution of lymphomas in Lebanon: five-year single institution experience. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[28]  J. Cerhan,et al.  Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium , 2008, International journal of cancer.

[29]  H. Adami,et al.  The non‐Hodgkin lymphomas: A review of the epidemiologic literature , 2007, International journal of cancer.

[30]  G. Marks,et al.  Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. , 1997, British Journal of Cancer.